Lifecore Biomedical LFCR reported its Q3 earnings results on Thursday, June 1, 2023 at 07:15 AM.
Here's what investors need to know about the announcement.
Earnings
Lifecore Biomedical missed estimated earnings by 69.23%, reporting an EPS of $-0.22 versus an estimate of $-0.13.
Revenue was down $25.47 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.27 which was followed by a 67.32% drop in the share price the next day.
Here's a look at Lifecore Biomedical's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|
EPS Estimate | 0.03 | -0.13 | -0.01 |
EPS Actual | -0.24 | -0.32 | -0.01 |
Revenue Estimate | 54.54M | 42.74M | 45.55M |
Revenue Actual | 38.80M | 43.35M | 47.63M |
To track all earnings releases for Lifecore Biomedical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.